the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric Cancer

NCT05235932 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 570

Last updated 2022-02-11

No results posted yet for this study

Summary

To evaluate the clinical efficacy (safety, feasibility and long-term efficacy) of robotic radical total gastrectomy and laparoscopic radical total gastrectomy in patients with locally advanced middle and upper gastric adenocarcinoma (CT2-4A, N-/+, M0) .

Conditions

Interventions

PROCEDURE

Robotic radical total gastrectomy with D2 lymphadenectomy

Most surgical procedures are performed using the robot system.

PROCEDURE

Laparoscopic radical total gastrectomy with D2 lymphadenectomy

Without the robot system, Most surgical procedures are performed using laparoscopic equipment.

Sponsors & Collaborators

  • Chinese PLA General Hospital

    collaborator OTHER
  • Tianjin Medical University Cancer Institute and Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Nanchang University

    collaborator OTHER
  • Lanzhou Military Region General Hospital

    collaborator UNKNOWN
  • Gansu Provincial Hospital

    collaborator OTHER
  • Southwest Hospital, China

    collaborator OTHER
  • First Affiliated Hospital of Guangxi Medical University

    collaborator OTHER
  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER
  • Second Xiangya Hospital of Central South University

    collaborator OTHER
  • Hebei Medical University Fourth Hospital

    collaborator OTHER
  • The Affiliated Hospital of Qingdao University

    collaborator OTHER
  • The Second Affiliated Hospital of Dalian Medical University

    collaborator OTHER
  • Fujian Medical University

    lead OTHER

Principal Investigators

  • Chang-ming Huang, MD · Fujian Medical University Union Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-20
Primary Completion
2024-02-20
Completion
2027-02-20

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05235932 on ClinicalTrials.gov